BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s): BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp.

<< Previous

Bullboard Posts

Next >>

Post by moneywagonon Apr 19, 2023 12:13pm

361 Views

Post# 35403199

BIOV CEO INTERVIEW JAMES PASSIN

 		Hey DOXIE just sharing, did you see the interview??
 		Anon has been on a continuous dump for over a month now. The good side is every sell is a strong hold share holder. Not my first rodeo (pharma)
 		I have posted many times FDA approval stocks are tough. All pharma companies looking for FDA approval have a bull ring in their nose. 
 		Stocks as such are under the COMPLETE CONTROL of FDA. 
 		I see Anon dumping but is this a Bear or Bull trap? 
 		Just focus on Papilocare.........this product has a history of success, Papil is not a NEW product put out by BIOV. We are seeking distribution!!!
 		
 		Every sector that the government is in control of is in a complete SHAMBLES!!
 		The education system is in shambles
 		The Health care system is in shambles
 		The BANK system is in shambles...sheeesh 8 hikes for the average Canadian before you can buy a loaf of bread.
 		They WAITED TO LONG to increase. fact!!
 		
 		FDA is the problem for pharma sector. I just thought it would be a tiny bit different investing in BIOV octopus arm for PAPILOCARE. not talking about all the other octopus arms.
 		Papilocare FDA approval........................ should be alot further along than it currently is. 
 		
 		@accesswire The Power Play by The Market Herald Releases New Interviews with Reunion Gold Corp, Numinus Wellness, Core Assets, Blockmate Ventures, BioVaxys Tech, Carlyle Commodities and Belmont Resources Discussing Their Latest News @accesswire/the-power-play-by-the-market-herald-releases-new-interviews-597ab $NUMI $BIOV $CCC $MATE $CC $RGD #news/psychedelics #news/drug-discovery-development #news/treatment-clinics #news/healthcare #news/biotech #news/mining #news/blockchain #news/digital-asset-management #news/capital-markets